34 programming-"the"-"DAAD"-"IMPRS-ML"-"Virginia-Tech"-"FEMTO-ST" "https:" "UCL" Fellowship positions
Sort by
Refine Your Search
-
Social and Historical Sciences. For more information, please visit http://www.ucl.ac.uk/about UCL Mechanical Engineering UCL Mechanical Engineering has been pioneering the development of engineering
-
Society until 31 May 2028 in the first instance with the possibility of extension. For a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs
-
neuroscience, cardiovascular neurophysiology, and neural computation. Researchers have access to state of the art facilities (https://www.ucl.ac.uk/science-technology-platforms/ ) and the department has close
-
addressed to Professor Gabriele Lignani (g.lignani at ucl.ac.uk). For a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs ) and search using
-
neuroscience, cardiovascular neurophysiology, and neural computation. Researchers have access to state of the art facilities (https://www.ucl.ac.uk/science-technology-platforms/) and the department has close
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and